Evidence map›Paper›PMID 42889098›Full record

ArticleFrontiers in oncology2026

Retroauricular approach for carotid body tumor resection: a case report.

Yi-Chan Lee, Wen-Yu Wu, Yao-Chang Wang

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yi-Chan LeeDepartment of Otolaryngology - Head and Neck Surgery, Chang Gung Memorial Hospital, Keelung, Taiwan.
Wen-Yu Wu *College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Yao-Chang Wang *Department of Cardiovascular Surgery, Chang Gung Memorial Hospital, Keelung, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Carotid body tumors (CBTs) are rare and highly vascular paragangliomas arising at the carotid bifurcation. Surgical resection remains the standard treatment for CBTs. However, the conventional transcervical approach inevitably leaves a visible cervical scar, which may negatively affect quality of life in patients with cosmetic concerns. Case presentation: A 27-year-old woman presented with a progressively enlarging right neck mass over a 6-month period. Ultrasonography demonstrated a hypervascular lesion surrounding the carotid arteries, and fine-needle aspiration was avoided because of the vascular nature of the tumor. Contrast-enhanced computed tomography revealed a 4-cm enhancing mass at the carotid bifurcation, highly suggestive of a CBT. Because the patient expressed concern regarding a visible cervical scar, a retroauricular approach was selected after thorough discussion of its potential risks and benefits. The operation was performed by a head and neck surgeon with intraoperative assistance from a vascular surgeon. Complete tumor resection was successfully achieved despite the need for repair of two small arterial defects encountered during tumor mobilization. The operative time was 300 minutes, and the estimated blood loss was 900 mL. The postoperative course was uneventful, and no major complications or tumor recurrence were observed during 12 months of follow-up. The patient reported satisfaction with the cosmetic outcome, although no objective cosmetic assessment was performed. Conclusion: In carefully selected patients with Shamblin type I or II CBT, the retroauricular approach may represent a feasible hidden-scar alternative to the conventional transcervical approach.

Indexed as

carotid body tumorhead and neckquality of liferetroauricularsurgery

Identifiers

PMID42889098
PMCPMC13668566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.